[III. Chronic myeloid leukemia-effectiveness of second generation tyrosine kinase inhibitors for first line treatment of chronic myeloid leukemia-].
作者信息
Takahashi Naoto
机构信息
Department of Hematology, Nephrology, and Rheumatology, Akita University, 1-1-1 Hondo, Akita City, Akita, 010-8543, Japan.
出版信息
Gan To Kagaku Ryoho. 2012 May;39(5):743-6.
PMID:22701901
Abstract
摘要
相似文献
1
2
Novel tyrosine kinase inhibitors in chronic myelogenous leukemia.慢性粒细胞白血病中的新型酪氨酸激酶抑制剂
Curr Opin Oncol. 2006 Nov;18(6):578-83. doi: 10.1097/01.cco.0000245314.97638.d3.
3
Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients.匈牙利酪氨酸激酶抑制剂耐药慢性髓性白血病患者的附加染色体异常、BCR-ABL 酪氨酸激酶结构域突变和临床结局。
Acta Haematol. 2012;127(1):34-42. doi: 10.1159/000331472. Epub 2011 Oct 14.
4
New tyrosine kinase inhibitors in chronic myeloid leukemia.慢性髓性白血病中的新型酪氨酸激酶抑制剂
Haematologica. 2005 Apr;90(4):534-41.
5
Comparative In vitro cellular data alone are insufficient to predict clinical responses and guide the choice of BCR-ABL inhibitor for treating imatinib-resistant chronic myeloid leukemia.仅比较体外细胞数据不足以预测临床反应并指导用于治疗伊马替尼耐药慢性髓性白血病的BCR-ABL抑制剂的选择。
J Clin Oncol. 2010 Apr 10;28(11):e169-71; author reply e172. doi: 10.1200/JCO.2009.26.4945. Epub 2010 Mar 1.
6
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation.α干扰素可能恢复F317L突变的费城染色体阳性急性淋巴细胞白血病对酪氨酸激酶抑制剂的敏感性。
Br J Haematol. 2009 Jul;146(2):227-30. doi: 10.1111/j.1365-2141.2009.07747.x. Epub 2009 May 26.
7
Mutational analysis in chronic myeloid leukemia: when and what to do?慢性髓性白血病的基因突变分析：何时做，做什么？
Curr Opin Hematol. 2011 Mar;18(2):111-6. doi: 10.1097/MOH.0b013e32834399ef.
8
[New perspective in the treatment of chronic myeloid leukemia? gene silencing therapy].[慢性粒细胞白血病治疗的新视角？基因沉默疗法]
Magy Onkol. 2012 Mar;56(1):16-22. Epub 2011 Sep 30.
9
Imatinib mesylate therapy in chronic myeloid leukaemia: the floodgates opened.甲磺酸伊马替尼治疗慢性髓性白血病：闸门打开了。
J Assoc Physicians India. 2007 Feb;55:99-100.
10
New insights into the pathogenesis of chronic myeloid leukaemia: towards a path to cure.慢性髓性白血病发病机制的新见解：通向治愈之路
Neth J Med. 2011 Oct;69(10):430-40.
Zotero 插件